Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 3640 | 140 | 0.1832 | 0.1915 | 0.0385 | 0.0418 |
A-375 | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 2 | 3900 | 189 | 0.1943 | 0.1915 | 0.0485 | 0.0418 |
A-375 | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 3917 | 151 | 0.1971 | 0.1915 | 0.0385 | 0.0418 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 1 | 3373 | 297 | 0.5101 | 0.4962 | 0.0881 | 0.0847 |
WM-115 | Vemurafenib | Defactinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 3017 | 261 | 0.6588 | 0.6656 | 0.0865 | 0.0837 |
WM-115 | Vemurafenib | Defactinib | 1.000 | 0.000 | uM | 72 | hr | 2 | 2788 | 413 | 0.5677 | 0.5412 | 0.1481 | 0.1460 |
WM-115 | Vemurafenib | Defactinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 2465 | 330 | 0.5103 | 0.5412 | 0.1339 | 0.1460 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 3 | 3226 | 262 | 0.4915 | 0.4962 | 0.0812 | 0.0847 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 2 | 3208 | 272 | 0.4869 | 0.4962 | 0.0848 | 0.0847 |
COLO 858 | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 3752 | 367 | 0.4835 | 0.4885 | 0.0978 | 0.0896 |
COLO 858 | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 3991 | 355 | 0.5194 | 0.4885 | 0.0890 | 0.0896 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 2 | 2562 | 425 | 0.3053 | 0.3034 | 0.1659 | 0.1673 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 3381 | 232 | 0.1648 | 0.1538 | 0.0686 | 0.0753 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 3197 | 255 | 0.1540 | 0.1538 | 0.0798 | 0.0753 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 2950 | 229 | 0.1424 | 0.1538 | 0.0776 | 0.0753 |
A-375 | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 2 | 4429 | 94 | 0.2727 | 0.2659 | 0.0212 | 0.0217 |
A-375 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 13441 | 248 | 0.6323 | 0.4565 | 0.0185 | 0.0200 |
A-375 | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 3 | 4768 | 111 | 0.2929 | 0.2659 | 0.0233 | 0.0217 |
COLO 858 | Vemurafenib | JNK-IN-8 | 3.160 | 0.000 | uM | 72 | hr | 2 | 1051 | 926 | 0.0207 | 0.0290 | 0.8811 | 0.8526 |
A-375 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 8056 | 164 | 0.3782 | 0.4565 | 0.0204 | 0.0200 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 1 | 2454 | 395 | 0.2941 | 0.3034 | 0.1610 | 0.1673 |
A-375 | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 3774 | 124 | 0.1848 | 0.1953 | 0.0329 | 0.0349 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 2637 | 462 | 0.3107 | 0.3034 | 0.1752 | 0.1673 |
MMAC-SF | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 756 | 273 | 0.3854 | 0.3431 | 0.3611 | 0.3687 |
MMAC-SF | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 642 | 245 | 0.3168 | 0.3431 | 0.3816 | 0.3687 |